UAE launches Sinopharm vaccine trial for children under 18
- 3 years ago
DUBAI - Some members of Abu Dhabi's ruling family are participating in a trial administering China's Sinopharm (1099.HK) COVID-19 vaccine to children aged 3-17, the emirate's media office said.
The trial will monitor the immune response of 900 children "in preparation to vaccinate children in the near future", Abu Dhabi Media Office said in a Twitter post on Wednesday.
Sheikh Theyab bin Mohammed, a son of the United Arab Emirate's de facto ruler and Abu Dhabi's crown prince Sheikh Mohammed bin Zayed Al Nahyan, accompanied his children, nieces and nephews to participate in the immune bridge study, it said.
The UAE in May approved the Pfizer-BioNTech vaccine for emergency use in children aged 12-15. Dubai, the second-largest member of the UAE federation, started inoculating that age group this month.
Source: Reuters
Comments